Antoinette Josephine Wozniak MD

Oncology•Pittsburgh, PA

Hematologic Oncology

Professor of Medicine, University of Pittsburgh

Join to View Full Profile

5115 Centre AvenueRm 568Pittsburgh, PA 15232
Phone+1 412-623-2696
Fax+1 412-648-6579

Education & Training

University of FloridaFellowship, Hematology and Medical Oncology, 1980 - 1983
University at BuffaloResidency, Internal Medicine, 1977 - 1980
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1977

Certifications & Licensure

MI State Medical License 1983 - 2026
PA State Medical License 2018 - 2024
FL State Medical License 1980 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer Start of enrollment: 1995 Oct 01
Completed
Phase 2
S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer Start of enrollment: 2004 Sep 01
Completed
Phase 2
S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer Start of enrollment: 2004 Sep 01
Terminated
Not Applicable
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery Start of enrollment: 2005 Nov 01
Completed
Phase 2
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer Start of enrollment: 2007 Jul 01
Completed
Phase 2
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
RECRUITING
NA
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
COMPLETED
PHASE1, PHASE2
Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01
Terminated
Not Applicable
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2014 Aug 01
RECRUITING
NA
Join now to see all

Publications & Presentations

PubMed

Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.
Dylan Fortman, Hong Wang, Robert VanderWeele, Terry Evans, James G Herman
Clinical Lung Cancer. 2025-01-01
Short Report of a Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM).
Antoinette J Wozniak, Bryan Schneider, Gregory P Kalemkerian, Bobby Daly, Wei Chen
Clinical Lung Cancer. 2023-09-01
1 citations
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1-Monotherapy Pretreated, Advanced NSCLC: Results From a P...
Edward B Garon, Alexander I Spira, Sarah B Goldberg, Jamie E Chaft, Vassiliki Papadimitrakopoulou
Journal of Thoracic Oncology. 2023-08-01

Lectures

A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM).
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Press Mentions

Lung Cancer Research Foundation Partners with Israel Cancer Research Fund for Collaborative Research InitiativeFebruary 18th, 2025

Committees

Member, 2015 Update Committee, American Society of Clinical Oncology (ASCO) 2015 - Present

Professional Memberships

American Society of Clinical Oncology - ASCO
Fellow
Alpha Omega Alpha Honor Medical Society - AOA
Member
American Association for Cancer Research - AACR
Member
American College of Physicians - ACP
Fellow
International Association for the Study of Lung Cancer
Member